Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1984 | 12-1983 | |
| Operating Expenses | 1,095 | 121 |
| Operating Income | -1,095 | -121 |
| Other Income | 41 | 2 |
| Pre-tax Income | -1,055 | -119 |
| Net Income Continuous | -1,055 | -119 |
| Net Income | $-1,055 | $-119 |
| EPS Basic Total Ops | -60.27 | -8.91 |
| EPS Basic Continuous Ops | -60.27 | -8.91 |
| EPS Diluted Total Ops | -60.27 | -8.91 |
| EPS Diluted Continuous Ops | -60.27 | -8.91 |
| EBITDA(a) | $-1,095 | $-121 |